Shengxiang Ren
- Oncology top 0.5%
- Lung Cancer Research Studies 80
- Cancer Immunotherapy and Biomarkers 64
- Colorectal Cancer Treatments and Studies 31
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 34
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 143
- Lung Cancer Diagnosis and Treatment 38
- Immunology top 2%
- Immunotherapy and Immune Responses 13
- Molecular Biology top 5%
- RNA modifications and cancer 14
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shengxiang Ren
240 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 4.4k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 3.8k
- Immunology 1.1k
- Molecular Biology 2.4k
Countries citing papers authored by Shengxiang Ren
This map shows the geographic impact of Shengxiang Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxiang Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxiang Ren more than expected).
Fields of papers citing papers by Shengxiang Ren
This network shows the impact of papers produced by Shengxiang Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxiang Ren. The network helps show where Shengxiang Ren may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengxiang Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 40 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 18 | |
| 10 | 2019 | 277 | |
| 11 | 2019 | 121 | |
| 12 | 2019 | 23 | |
| 13 | 2019 | 1 | |
| 14 | 2018 | 34 | |
| 15 | 2017 | 2 | |
| 16 | 2016 | 12 | |
| 17 | 2015 | 8 | |
| 18 | 2014 | 50 | |
| 19 | 2011 | 113 | |
| 20 | 2010 | 60 |
About Shengxiang Ren
Shengxiang Ren is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 249 papers that have together received 7.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (143 papers), Lung Cancer Research Studies (80 papers), Cancer Immunotherapy and Biomarkers (64 papers), Lung Cancer Diagnosis and Treatment (38 papers), Cancer Genomics and Diagnostics (34 papers), Colorectal Cancer Treatments and Studies (31 papers), RNA modifications and cancer (14 papers) and Immunotherapy and Immune Responses (13 papers). The work is most often cited by research in Oncology (4.4k citations), Cancer Research (1.8k citations) and Pulmonary and Respiratory Medicine (3.8k citations). Shengxiang Ren has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tao Jiang, Chunxia Su, Xuefei Li, Caicun Zhou, Chao Zhao, Caicun Zhou, Caicun Zhou, Guanghui Gao, Xiaoxia Chen and Fei Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.